InnoUp was founded in 2015 in Pamplona (Navarre, Spain). It is a clinical stage company focused on nanotechnology innovation, that develops oral drug delivery solutions. The company has a technology platform, protected by international patents, based on the use of nanoparticles.
InnoUp has advanced 2 programs into clinical stages: an oral Peanut Allergy Vaccine (INP20) and an Oral Paclitaxel for the treatment of Breast Cancer (INP12). In order to take advantage of the most cutting-edge discoveries, we maintain a network of collaborators from Universities and Research Centers.